))
ICT Ep16: Revolutionizing Cancer Trial Enrollment with Selin Kurnaz (Part 1 of 3)
Manage episode 444326882 series 3578161
Inhoud geleverd door Liam Eves and Ted Trafford, Liam Eves, and Ted Trafford. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door Liam Eves and Ted Trafford, Liam Eves, and Ted Trafford of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.
In this episode of Innovating Clinical Trials, hosts Liam Eves and Ted Trafford are joined by Selin Kurnaz, CEO and founder of Massive Bio, an AI-driven platform designed to connect cancer patients with clinical trials.
Our conversation dives deep into the challenges of patient awareness, access, and logistical hurdles in trial enrollment. Selin shares how her personal experience with her uncle’s cancer diagnosis led to the creation of Massive Bio and her mission to streamline trial enrollment using technology.
We discuss the "Last Mile" problem and walk through how combining technological scale with personalized concierge services can help patients not only find relevant trials but also overcome the logistical and financial barriers that can prevent participation. With insights into the complexities of the clinical trial landscape, the discussion highlights the critical steps needed to bridge the gap between patients and life-saving treatments.
28 afleveringen
Delen
